Muscular dystrophies (MDs) encompass a wide variety of inherited disorders that are
characterized by loss of muscle tissue associated with a progressive reduction in muscle …

The research on laminin α2 chain-deficient congenital muscular dystrophy (LAMA2-CMD)
advanced rapidly in the last few decades, largely due to availability of good mouse models …

Congenital muscular dystrophy with laminin α2 chain-deficiency (LAMA2-CMD) is a severe
neuromuscular disorder without a cure. Using transcriptome and proteome profiling as well …

Deficiency of laminin α2 chain leads to a severe form of congenital muscular dystrophy
(LAMA2-CMD), and dystrophic symptoms progress rapidly in early childhood. Currently …

LAMA2-related congenital muscular dystrophy (LAMA2-CMD), characterized by laminin-α2
deficiency, is debilitating and ultimately fatal. To date, no effective therapy has been …

Congenital muscular dystrophy with laminin α2 chain-deficiency (LAMA2-CMD) is a severe
muscle disorder with complex underlying pathogenesis. We have previously employed …

Dysferlinopathies are a group of muscular dystrophies caused by genetic deficiency of the
protein dysferlin. Manifesting post-growth, the disease is characterised by progressive …

Introductory paragraph Identification of protective and/or pathogenic genetic modifiers
provides important insight into the heterogeneity of disease presentations in individuals …

La Distròfia Muscular de Duchenne és una malaltia devastadors y progressiva que
actualment no disposa de cap tractament curatiu i només es poden oferir teràpies pal …

LAMA2-congenital muscular dystrophy (LAMA2-CMD) is characterized by muscle weakness
and hypotonia present at birth and, currently, no treatment or cure are available. LAMA2 …